[1]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志, 2003, 11 (2) ∶71.
|
[2]李淑梅.胰岛素抵抗与高血压及抗高血压药物的关系[J].国外医学心血管分册, 2000, 27∶14-18.
|
[3]李光伟, 姜亚云, 杨文英, 等.胰岛素抵抗引起的代偿性高胰岛素血症预测非糖尿病人群血压升高[J].中国医学科学院学报, 2002, 24∶481-485.
|
[4]Park SH, KimBI, Yun Jw, et al.Insulin resistance and C-reactiveprotein as independent risk factors for non-alcoholic fatty liver dis-ease in non-obese Asian men[J].J Gastroenterol Hepatol, 2004, 19 (6) ∶694-698.
|
[5]范小芬, 邓银泉.非酒精性脂肪肝患者的胰岛素抵抗状态[J].浙江医学.2002, 24 (5) ∶267-269.
|
[6]魏良洲, 杨正武.瘦素、胰岛素在非酒精性脂肪肝发病中的作用[J].临床肝胆病杂志.2006, 22 (1) ∶72.
|
[7]Donati G, StagniB, Piscaglia F, et al.Increased prevalence of fattyliver in arterial hypertensive patients with nomal liver enzymes:role ofinsulin resistance[J].Gut, 2004, 53 (7) ∶923-924.
|
[8]Marchesini G, Brizi M, Bianchi G, et al.Non-alcoholic fatty liverdisease:a feature of the metabolic syndrome[J].Diabetes, 2001, 50∶1844-1850.
|